A phase 3 randomized controlled trial of a COVID-19 recombinant vaccine S-268019-b versus ChAdOx1 nCoV-19 in Japanese adults | Scientific Reports
A phase 3 randomized controlled trial of a COVID-19 recombinant vaccine S-268019-b versus ChAdOx1 nCoV-19 in Japanese adults | Scientific Reports,Smart Airの購入サポート金利0%のご案内,StopCOVID19 Japan 新型コロナウイルス対策ダッシュボードの更新終了と、NIID感染症オープンデータの収集開始のお知らせ,Biomed Industries.™ News- Press Release-Biomed announced its Phase 1B clinial results of NA-831 for the treatment of Major Depressive Disorder.,ケンタウロス」と呼ばれるオミクロン株亜系統BA.2.75は日本でも広がるのか?(忽那賢志) - エキスパート - Yahoo!ニュース